Teva Pharma Industries Ltd ADR

Yahoo Finance • 5 hours ago

Quant check on David Einhorn's Greenlight Capital holdings post Q1

[Close up image of wooden cubes with alphabet Q1 on office desk.] mohd izzuan David Einhorn's Greenlight Capital funds gave a return of 6.5% in Q1 vs. a broader market drop of 4.4% in the S&P 500 index. The significant winners in the quar... Full story

Yahoo Finance • 2 days ago

BofA Raises its Price Target on Teva Pharmaceutical (TEVA) to $42

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the 8 Cheap Large Cap Stocks to Buy Now. On April 9, 2026, BofA raised the price target on Teva Pharmaceutical Industries Limited (NYSE:TEVA) to $42 from $38 and maintained a Bu... Full story

Yahoo Finance • 7 days ago

Australia Drug Delivery Devices Market Trends by Type of Product, Application Area and End-user - Forecast to 2035

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Australia Drug Delivery Devices Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area and End-user" has been added to ResearchAndMarke... Full story

Yahoo Finance • 7 days ago

What Makes C.H. Robinson (CHRW) a Standout From Its Peers?

TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities finished the year on a positive note, with the S&P 500 T... Full story

Yahoo Finance • 7 days ago

Factors Supporting Teva Pharmaceutical’s (TEVA) Long-Term Profitability

TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities finished the year on a positive note, with the S&P 500 T... Full story

Yahoo Finance • 7 days ago

Dollar Tree (DLTR) Gained from Lower Freight Costs and Favorable Product Mix

TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities finished the year on a positive note, with the S&P 500 T... Full story

Yahoo Finance • 11 days ago

Mental Health Market Set to Surpass USD 668.62 Billion by 2035, Owing to the Increased Adoption of Digital Care and AI-Driven Therapies – SNS Insider

Austin, United States, April 03, 2026 (GLOBE NEWSWIRE) -- As per SNS Insider, The global Mental Health Market was estimated at USD 449.96 billion in 2025 and is projected to hit USD 668.62 billion by 2035, recording a CAGR of 4.04% over... Full story

Yahoo Finance • 14 days ago

Immunic appoints biopharmaceutical executive Jon Congleton to board

Immunic appoints biopharmaceutical executive Jon Congleton to board Proactive uses images sourced from Shutterstock Immunic Inc (NASDAQ:IMUX, FRA:10VA) has announced the appointment of veteran biopharmaceutical executive Jon Congleton to... Full story

Yahoo Finance • 14 days ago

Blackstone closes largest ever private funding investment round at $6.3bn

Private investment platform Blackstone closed a funding raise that has brought in $6.3bn in capital to support its ongoing life sciences investment strategy – marking the largest life sciences private fund ever raised. The firm’s dedicate... Full story

Yahoo Finance • 15 days ago

Teva gains approval of biosimilar of Amgen's Prolia

[Teva Canada Markham manufacturing facility, Ontario, Canada.] JHVEPhoto * The US FDA has approved Teva Pharmaceutical Industries' (TEVA [https://seekingalpha.com/symbol/TEVA]) Ponlimsi (denosumab-adet), a biosimilar to Amgen's (AMGN [h... Full story

Yahoo Finance • 18 days ago

Clinical Nutrition for Diabetes Care Market Report 2026-2030 Featuring Profiles of Key Players - Pfizer, Bayer, Sanofi-Aventis, Abbott Labs, Roche and More

Company Logo The rise of diabetes, demand for specialized nutrition, digital monitoring tools, and home-based management are key trends driving market growth Clinical Nutrition for Diabetes Care MarketClinical Nutrition for Diabetes Care... Full story

Yahoo Finance • 23 days ago

This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition

Key Points Bridger Management sold 47,841 shares of Masimo in the fourth quarter. The move resulted in the quarter-end position value decreasing by $7.06 million. The position was previously 3.8% of fund AUM as of the prior quarter.10 sto... Full story

Yahoo Finance • 25 days ago

Corcept rises after insider buy worth over $3M

[$10 Banknote Stacking, Green Up Arrow Rise] spawns * Corcept Therapeutics (CORT [https://seekingalpha.com/symbol/CORT]) traded higher on Friday after the company’s board member Leonard Baker Jr. disclosed that he purchased shares of th... Full story

Yahoo Finance • 26 days ago

Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026

TEL AVIV, Israel and PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2026 financial results on Wednesd... Full story

Yahoo Finance • 26 days ago

Teva Releases Q1 2026 Aide Memoire

TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2026 Aide Memoire is available on the “Investors” page on its website. Q1 2026 Aide Memoire Teva... Full story

Yahoo Finance • 26 days ago

Alvotech Q4 Earnings Call Highlights

Alvotech logo Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem Alvotech (NASDAQ:ALVO) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline progress on commercial launches, manufacturin... Full story

Yahoo Finance • last month

Blackstone (BX) Commits $400 Million With Teva to Advance Duvakitug Clinical Development

Blackstone Inc. (NYSE:BX) is one of the 10 Best Asset Management Stocks to Buy Right Now.Blackstone (BX) Commits $400 Million With Teva to Advance Duvakitug Clinical Development Top 100 Places Where the Rich People Own Real Estate On Mar... Full story

Yahoo Finance • last month

Forget Teva: This Dividend Top Dog Is the Real Value Buy Today

Key Points Teva Pharmaceutical is a bit of a turnaround story, as the company continues a major business overhaul. This competitor, with a huge 6.3% yield, has hit a few setbacks, but it is still just business as usual.10 stocks we like b... Full story

Yahoo Finance • last month

Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding

Key Points Form 13Fs help investors track which stocks and exchange-traded funds (ETFs) Wall Street's most successful money managers bought and sold in the latest quarter. Profit-taking looks to have been on billionaire Stanley Druckenmi... Full story

Yahoo Finance • last month

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is currently in phase 3 clinical studies for ulcerative colitis (UC) and Crohn’s disease (CD)Agreem... Full story